ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
1. Eight G-Rex Grants worth $2 million awarded for CGT manufacturing advancements. 2. CIRM funding supports non-profit academic GMP manufacturing facilities in California. 3. G-Rex platform widely adopted for CAR-T cell therapies and clinical trials. 4. California aims to be a hub for cell and gene therapy innovations. 5. ScaleReady's new programs aim to enhance CGT manufacturing efficiency.